Pfizer and BioNTech to Supply EU with up to 200M Doses of BNT162B2 Against COVID-19

November 12, 2020 Auto Bot Agreement, BioNTech, BNT162b2, Clinical Trials, EU, European Commission, Pfizer, Signs, Supply 0

Shots:

  • The companies sign an agreement with the EC to supply 200M doses of BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2 to EU member states, with an option to request an additional 100M doses
  • Deliveries are anticipated to start by the end of 2020, following clinical success and regulatory authorization. The companies expect to produce ~1.3B doses in 2021 globally
  • Pfizer and BioNTech initiated a rolling submission to the EMA in Oct’2020 and will continue a regular and open dialogue with the EMA providing results from their ongoing P-III study

Click here­ to­ read full press release/ article | Ref: Pfizer | Image: MedPage Today

The post Pfizer and BioNTech to Supply EU with up to 200M Doses of BNT162B2 Against COVID-19 first appeared on PharmaShots.